This story has been corrected to note that a single arm of a Brazilian hydroxychloroquine trial was ended over cardiotoxicity concerns but that the rest of the trial has continued. We regret the error.
NEW YORK – An international consortium of researchers has used protein interaction studies to identify antiviral agents that could be effective against SARS-CoV-2.